Cargando…

SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251

BACKGROUND: Emergence of viral variants that escape CTL control is a major hurdle in HIV vaccination unless such variants affect gene regions that are essential for virus replication. Vaccine-induced multispecific CTL could also be able to control viral variants replication. To explore these possibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Villefroy, Pascale, Letourneur, Franck, Coutsinos, Zoe, Mortara, Lorenzo, Beyer, Christian, Gras-Masse, Helene, Guillet, Jean-Gerard, Bourgault-Villada, Isabelle
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1613241/
https://www.ncbi.nlm.nih.gov/pubmed/16945152
http://dx.doi.org/10.1186/1743-422X-3-65
_version_ 1782130478501855232
author Villefroy, Pascale
Letourneur, Franck
Coutsinos, Zoe
Mortara, Lorenzo
Beyer, Christian
Gras-Masse, Helene
Guillet, Jean-Gerard
Bourgault-Villada, Isabelle
author_facet Villefroy, Pascale
Letourneur, Franck
Coutsinos, Zoe
Mortara, Lorenzo
Beyer, Christian
Gras-Masse, Helene
Guillet, Jean-Gerard
Bourgault-Villada, Isabelle
author_sort Villefroy, Pascale
collection PubMed
description BACKGROUND: Emergence of viral variants that escape CTL control is a major hurdle in HIV vaccination unless such variants affect gene regions that are essential for virus replication. Vaccine-induced multispecific CTL could also be able to control viral variants replication. To explore these possibilities, we extensively characterized CTL responses following vaccination with an epitope-based lipopeptide vaccine and challenge with pathogenic SIVmac251. The viral sequences corresponding to the epitopes present in the vaccine as well as the viral loads were then determined in every macaque following SIV inoculation. RESULTS: In most cases, the emergence of several viral variants or mutants within vaccine CTL epitopes after SIV challenge resulted in increased viral loads except for a single macaque, which showed a single escape viral variant within its 6 vaccine-induced CTL epitopes. CONCLUSION: These findings provide a better understanding of the evolution of CD8+ epitope variations after vaccination-induced CTL expansion and might provide new insight for the development of an effective HIV vaccine.
format Text
id pubmed-1613241
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-16132412006-10-17 SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251 Villefroy, Pascale Letourneur, Franck Coutsinos, Zoe Mortara, Lorenzo Beyer, Christian Gras-Masse, Helene Guillet, Jean-Gerard Bourgault-Villada, Isabelle Virol J Study Protocol BACKGROUND: Emergence of viral variants that escape CTL control is a major hurdle in HIV vaccination unless such variants affect gene regions that are essential for virus replication. Vaccine-induced multispecific CTL could also be able to control viral variants replication. To explore these possibilities, we extensively characterized CTL responses following vaccination with an epitope-based lipopeptide vaccine and challenge with pathogenic SIVmac251. The viral sequences corresponding to the epitopes present in the vaccine as well as the viral loads were then determined in every macaque following SIV inoculation. RESULTS: In most cases, the emergence of several viral variants or mutants within vaccine CTL epitopes after SIV challenge resulted in increased viral loads except for a single macaque, which showed a single escape viral variant within its 6 vaccine-induced CTL epitopes. CONCLUSION: These findings provide a better understanding of the evolution of CD8+ epitope variations after vaccination-induced CTL expansion and might provide new insight for the development of an effective HIV vaccine. BioMed Central 2006-08-31 /pmc/articles/PMC1613241/ /pubmed/16945152 http://dx.doi.org/10.1186/1743-422X-3-65 Text en Copyright © 2006 Villefroy et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Protocol
Villefroy, Pascale
Letourneur, Franck
Coutsinos, Zoe
Mortara, Lorenzo
Beyer, Christian
Gras-Masse, Helene
Guillet, Jean-Gerard
Bourgault-Villada, Isabelle
SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251
title SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251
title_full SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251
title_fullStr SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251
title_full_unstemmed SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251
title_short SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251
title_sort siv escape mutants in rhesus macaques vaccinated with nef-derived lipopeptides and challenged with pathogenic sivmac251
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1613241/
https://www.ncbi.nlm.nih.gov/pubmed/16945152
http://dx.doi.org/10.1186/1743-422X-3-65
work_keys_str_mv AT villefroypascale sivescapemutantsinrhesusmacaquesvaccinatedwithnefderivedlipopeptidesandchallengedwithpathogenicsivmac251
AT letourneurfranck sivescapemutantsinrhesusmacaquesvaccinatedwithnefderivedlipopeptidesandchallengedwithpathogenicsivmac251
AT coutsinoszoe sivescapemutantsinrhesusmacaquesvaccinatedwithnefderivedlipopeptidesandchallengedwithpathogenicsivmac251
AT mortaralorenzo sivescapemutantsinrhesusmacaquesvaccinatedwithnefderivedlipopeptidesandchallengedwithpathogenicsivmac251
AT beyerchristian sivescapemutantsinrhesusmacaquesvaccinatedwithnefderivedlipopeptidesandchallengedwithpathogenicsivmac251
AT grasmassehelene sivescapemutantsinrhesusmacaquesvaccinatedwithnefderivedlipopeptidesandchallengedwithpathogenicsivmac251
AT guilletjeangerard sivescapemutantsinrhesusmacaquesvaccinatedwithnefderivedlipopeptidesandchallengedwithpathogenicsivmac251
AT bourgaultvilladaisabelle sivescapemutantsinrhesusmacaquesvaccinatedwithnefderivedlipopeptidesandchallengedwithpathogenicsivmac251